INTEGRA Biosciences announces the appointment of a new board member

INTEGRA Biosciences is excited to welcome Line Stigen Raquet as a non-executive board member. Line has over 20 years’ leadership experience in the life sciences sectors, and her extensive business knowledge will contribute to INTEGRA’s continued growth.

Line is a biochemist, and her education and training have given her a firm foundation for success as an entrepreneur in various life sciences markets. Throughout her illustrious career to date, Line has demonstrated her competency in commercial and P&L functions at several major industry players – including Life Technologies, QIAGEN, Mettler Toledo and Malvern Panalytical – acquiring a deep knowledge of diagnostics, laboratory automation and drug discovery. Line has been the CEO of several companies, including Creoptix AG, a next-generation company developing bioanalytical solutions for drug discovery, which was successfully sold to Spectris plc in 2022. Most recently, Line was also CEO of Nanolive SA, a leading label-free live cell imaging and analysis company.

Line will fill the position recently vacated by Elmar Morscher, former CEO of INTEGRA. Elmar, together with 2 partners, founded Tecuria Engineering in 1988, which merged with INTEGRA in December 2001. He became CEO in January 2002, and held this role until the end of 2019, when he resigned and joined the board.

Elmar has been invaluable in ensuring INTEGRA’s success over the last 2 decades, transforming it from a small start-up to a leading international manufacturer of liquid handling solutions, and increasing turnover more than tenfold. Following his lengthy service and significant contributions to the firm, Elmar is now stepping down from his position and handing the baton to the newly appointed Line.

“I am delighted to become a non-executive board member at INTEGRA, an organization I have long admired for its values, culture and strong focus on innovation. Elmar has had a substantial positive impact on the company, and I aim to build on this impressive legacy with my specific experiences and knowledge. I very much look forward to working together with my new colleagues and using my skills to further INTEGRA’s goals of accelerating scientific discoveries.”

Line Stigen Raquet, non-executive board member INTEGRA Biosciences